Financials
- Market Capitalization 64.67 M
- Employee 21
- Founded 2015
- CEO N/A
- Website www.inmunebio.com
- Headquarter Nevada, United States
- FIGI BBG00LW94L98
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4158 | PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.22 USD | -1.61% | -8.27% | +15.09% | -12.86% | 65.22 M USD | ||
| 4160 | HYFT MindWalk Holdings Corp. - Common Stock | 1.39 USD | -2.11% | 0.00% | +6.92% | -31.19% | 64.93 M USD | ||
| 4165 | BOLD Boundless Bio, Inc. - Common Stock | 2.83 USD | -1.05% | -3.74% | +13.65% | +143.97% | 64.38 M USD | ||
| 4180 | HRTX Heron Therapeutics, Inc. - Common Stock | 0.33 USD | 0.00% | +3.13% | -32.65% | -75.56% | 62.65 M USD |
Frequently asked questions about INmune Bio Inc. Common stock
What is the INmune Bio Inc. Common stock stock price today?
The current price of INmune Bio Inc. Common stock (INMB) is 2.33. Over the past 24 hours, the stock has changed by -2.92%. Follow the INMB chart for real-time price dynamics.
What is the stock ticker of INmune Bio Inc. Common stock?
INmune Bio Inc. Common stock trades under the ticker INMB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is INmune Bio Inc. Common stock stock going up?
INMB has changed by +0.43% over the last week, +37.87% over the last month, and +16.50% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of INmune Bio Inc. Common stock?
INmune Bio Inc. Common stock currently has a market capitalization of 64.67 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were INmune Bio Inc. Common stock earnings last quarter?
Last quarter, INmune Bio Inc. Common stock reported earnings of -0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was INmune Bio Inc. Common stock revenue for the last quarter?
INmune Bio Inc. Common stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was INmune Bio Inc. Common stock net income for the last quarter?
INmune Bio Inc. Common stock reported net income of -1.27 M for the last quarter. The previous quarter showed -5.41 M, which means net income changed by +76.46%.
How many employees does INmune Bio Inc. Common stock have?
As of the latest available data, INmune Bio Inc. Common stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy INmune Bio Inc. Common stock stock?
You can buy INmune Bio Inc. Common stock (INMB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in INmune Bio Inc. Common stock stock?
Investing in INmune Bio Inc. Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INMB chart and related analysis on metatrader.com as part of your research.